Mazindol
生产企业：Wyeth ayerst laboratories, Novartis pharmaceuticals corp
Mazindol is a sympathomimetic used to treat obesity in combination with lifestyle modifications.
Mazindol is a sympathomimetic used to treat obesity in combination with lifestyle modifications.
Unlike other sympathomimetic appetite suppressants such as phentermine, mazindol is thought to inhibit the reuptake of norepinephrine rather than to cause its release.
Used in short-term (a few weeks) treatment of exogenous obesity in conjunction with a regimen of weight reduction based on caloric restriction, exercise, and behavior modification in patients with a body mass index of 30 kg of body weight per height in meters squared (kg/m) or in patients with a body mass index of 27 kg/m in the presence of risk factors such as hypertension, diabetes, or hyperlipidemia.
